Active, not recruiting
SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial
NCT04599140
- Conditions
- Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +31 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States